Track the Apotea AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Apotea AB (publ) has recorded 12 public disclosures. Market capitalisation: €7.8bn. The latest transaction was filed on 8 June 2026 (Purchase). Among the most active insiders: Pär Svärdson. The full history is openly available.
12
Insider Decl.
0
Thresholds
€4m
12 ops.
Buy Volume
·
0 ops.
Sell Volume
37Σ signal
Buys €4m· Sells
Fundamental score
Ranked 12,960 of 25,921 companies
52.0
score / 100
Value
42
Quality
62
FCF yld1.5%
Earn yld2.9%
EV/EBITDA17.4x
ROE28%
Gross mgn27%
Net mgn3.2%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.